Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHL TelemedicineLTS:0QMX -0.01%45 PB Ratio is 1.12 as of Jul. 15, 2026, which is 50% below its 10-year median of 2.24. GuruFocus rates LTS:0QMX with a GF Score™ of 45/100 and a GF Value™ of CHF2.00 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 607 Healthcare Providers & Services companies, SHL Telemedicine ranks better than 75.29% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-15), SHL Telemedicine's share price is CHF1.05. SHL Telemedicine's Book Value per Share for the quarter that ended in Dec. 2025 was CHF0.94. Hence, SHL Telemedicine's PB Ratio of today is 1.12.
The historical rank and industry rank for SHL Telemedicine's PB Ratio or its related term are showing as below:
LTS:0QMX'
s PB Ratio Range Over the Past 10 Years
Min: 0.39 Med: 2.24 Max: 6.22
Current: 1.12
During the past 13 years, SHL Telemedicine's highest PB Ratio was 6.22. The lowest was 0.39. And the median was 2.24.
LTS:0QMX's PB Ratio is ranked better than 75.29% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 2.01
vs LTS:0QMX: 1.12
During the past 12 months, SHL Telemedicine's average Book Value Per Share Growth Rate was -19.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -21.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -12.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -2.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of SHL Telemedicine was 24.80% per year. The lowest was -31.40% per year. And the median was -2.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
SHL Telemedicine PB Ratio Related Terms
SHL Telemedicine PB Ratio Historical Data
* Premium members only.
The historical data trend for SHL Telemedicine's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, SHL Telemedicine's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's PB Ratio distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
SHL Telemedicine (LTS:0QMX) has a PB Ratio of 1.12 as of Jul. 15, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on SHL Telemedicine and its competitors. This is 50% below median its historical median of 2.24. Over the past decade, SHL Telemedicine's PB Ratio has ranged from 0.39 to 6.22. According to the industry distribution chart, SHL Telemedicine ranks #150 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 24.7%.
Is SHL Telemedicine's PB Ratio too high?
SHL Telemedicine's current PB Ratio of 1.12 is 50% below median its 10-year median of 2.24. Over the past 10 years, this metric has ranged from a low of 0.39 to a high of 6.22. The Healthcare Providers & Services industry median PB Ratio is 2.01. SHL Telemedicine's value of 1.12 is 44.3% below this industry median. Based on the distribution chart, SHL Telemedicine ranks #150 out of 607 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, SHL Telemedicine has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #150 out of 607 companies for PB Ratio. This places SHL Telemedicine in the top 25% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.01. SHL Telemedicine's value of 1.12 is 44.3% below this benchmark. Historically, SHL Telemedicine's own PB Ratio has ranged from 0.39 to 6.22 over the past decade. While the company's 10-year median is 2.24 vs. the industry median of 2.01, SHL Telemedicine has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.01, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SHL Telemedicine's current PB Ratio of 1.12 is 44.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on SHL Telemedicine and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SHL Telemedicine's current PB Ratio is 1.12, which is 50% below median its own 10-year median of 2.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
Based on GuruFocus' analysis, SHL Telemedicine (LTS:0QMX) is currently considered Possible Value Trap. The stock's GF Value™ is CHF2.00, compared to a current price of CHF1.05 — trading 47.5% below its estimated fair value. The current PB Ratio is 1.12, which is 50% below median its 10-year median of 2.24 and 44.3% below the Healthcare Providers & Services industry median of 2.01. SHL Telemedicine's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For SHL Telemedicine (LTS:0QMX), the current PB Ratio is 1.12 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SHL Telemedicine (LTS:0QMX) Overvalued in 2026?
Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued.
The current stock price of CHF1.05 is trading 47.5% below its estimated GF Value™ of CHF2.00.
GuruFocus considers SHL Telemedicine to be Possible Value Trap.
Key valuation signals for LTS:0QMX:
PB Ratio: 1.12 (50% below median its 10-year median of 2.24)
GF Value™: CHF2.00 vs. price of CHF1.05 (47.5% below fair value)
Industry Position: 44.3% below the Healthcare Providers & Services median (#150 of 607)
No single metric tells the full story. See the LTS:0QMX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
45GF Score
Get the complete analysis for LTS:0QMX
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QMX has been successfully added to your 
